Position in CRSP
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$115,214
-$11,795 QoQ
Shares Held
2,422
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Financial Perspectives, Inc holds $818,923 across 15 Biotechnology names. CRSP ranks #3 (14.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
588 | $174,618 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
191 | $147,574 | |
| 3 | CRSP |
CRISPR Therapeutics AG
This page
|
2,422 | $115,214 | |
| 4 | ARGX |
Argenx SE
|
145 | $105,886 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,155 | $103,375 | |
| 6 | INCY |
Incyte Corp
|
1,000 | $94,120 | |
| 7 | GMAB |
Genmab A/S
|
1,333 | $35,764 | |
| 8 | CELC |
Celcuity Inc.
|
150 | $17,121 |
All Filings in CRSP
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $115,214 | 2,422 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $127,009 | 2,422 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $156,969 | 2,422 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $117,806 | 2,422 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $81,978 | 2,409 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $95,329 | 2,422 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $113,785 | 2,422 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $130,812 | 2,422 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $165,083 | 2,422 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $144,105 | 2,302 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $104,487 | 2,302 | Shares | Sole | 2024-01-10 | |
| 2023-06-30 | $129,234 | 2,302 | Shares | Sole | 2024-01-10 | |
| 2023-03-31 | $84,173 | 1,861 | Shares | Sole | 2024-01-10 | |
| 2022-12-31 | $75,649 | 1,861 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $125,733 | 1,924 | Shares | Sole | 2024-01-10 | |
| 2022-06-30 | $107,866 | 1,775 | Shares | Sole | 2024-01-10 | |
| 2022-03-31 | $111,416 | 1,775 | Shares | Sole | 2024-01-10 | |
| 2021-12-31 | $128,447 | 1,695 | Shares | Sole | 2024-01-10 | |
| 2021-09-30 | $358,735 | 3,205 | Shares | Sole | 2024-01-10 | |
| 2021-06-30 | $527,113 | 3,256 | Shares | Sole | 2024-01-10 | |
| 2021-03-31 | $45,358,906 | 372,252 | Shares | Sole | 2024-01-10 | |
| 2020-12-31 | $273,607 | 1,787 | Shares | Sole | 2024-01-10 | |
| 2020-09-30 | $74,690 | 893 | Shares | Sole | 2024-01-10 | |
| 2020-06-30 | $22,340 | 304 | Shares | Sole | 2024-01-10 | |
| 2020-03-31 | $12,892 | 304 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||